These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 19669732)
1. Potentiated startle as a measure of the negative affective consequences of repeated exposure to nicotine in rats. Engelmann JM; Radke AK; Gewirtz JC Psychopharmacology (Berl); 2009 Nov; 207(1):13-25. PubMed ID: 19669732 [TBL] [Abstract][Full Text] [Related]
2. Spontaneous nicotine withdrawal potentiates the effects of stress in rats. Jonkman S; Risbrough VB; Geyer MA; Markou A Neuropsychopharmacology; 2008 Aug; 33(9):2131-8. PubMed ID: 18033237 [TBL] [Abstract][Full Text] [Related]
3. Mecamylamine elicits withdrawal-like signs in rats following a single dose of nicotine. Harris AC; Manbeck KE; Schmidt CE; Shelley D Psychopharmacology (Berl); 2013 Jan; 225(2):291-302. PubMed ID: 22868410 [TBL] [Abstract][Full Text] [Related]
4. Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats. Bruijnzeel AW; Bishnoi M; van Tuijl IA; Keijzers KF; Yavarovich KR; Pasek TM; Ford J; Alexander JC; Yamada H Psychopharmacology (Berl); 2010 Dec; 212(4):485-99. PubMed ID: 20697697 [TBL] [Abstract][Full Text] [Related]
5. Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats. Paterson NE; Markou A Psychopharmacology (Berl); 2004 Apr; 173(1-2):64-72. PubMed ID: 14712336 [TBL] [Abstract][Full Text] [Related]
6. Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats. Bruijnzeel AW; Ford J; Rogers JA; Scheick S; Ji Y; Bishnoi M; Alexander JC Pharmacol Biochem Behav; 2012 Mar; 101(1):62-8. PubMed ID: 22182462 [TBL] [Abstract][Full Text] [Related]
7. Potentiated startle and hyperalgesia during withdrawal from acute morphine: effects of multiple opiate exposures. Harris AC; Hanes SL; Gewirtz JC Psychopharmacology (Berl); 2004 Nov; 176(3-4):266-73. PubMed ID: 15164157 [TBL] [Abstract][Full Text] [Related]
8. Withdrawal from repeated nicotine vapor exposure increases somatic signs of physical dependence, anxiety-like behavior, and brain reward thresholds in adult male rats. Martínez M; Espinoza VE; Garcia V; Uribe KP; Negishi K; Estevao IL; Carcoba LM; O'Dell LE; Khan AM; Mendez IA Neuropharmacology; 2023 Dec; 240():109681. PubMed ID: 37611823 [TBL] [Abstract][Full Text] [Related]
9. Elevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety. Harris AC; Gewirtz JC Psychopharmacology (Berl); 2004 Jan; 171(2):140-7. PubMed ID: 13680079 [TBL] [Abstract][Full Text] [Related]
10. The α3β4 nAChR partial agonist AT-1001 attenuates stress-induced reinstatement of nicotine seeking in a rat model of relapse and induces minimal withdrawal in dependent rats. Yuan M; Malagon AM; Yasuda D; Belluzzi JD; Leslie FM; Zaveri NT Behav Brain Res; 2017 Aug; 333():251-257. PubMed ID: 28693859 [TBL] [Abstract][Full Text] [Related]
11. Differential Effects of Nicotine and Nicotine Withdrawal on Fear Conditioning in Male Rats. Robble MA; Holloway IL; Ridener E; Webber CJ; Caine SB; Meloni EG; Desai RI; Carlezon WA Int J Neuropsychopharmacol; 2020 Jul; 23(7):469-479. PubMed ID: 32242615 [TBL] [Abstract][Full Text] [Related]
12. Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome. Panagis G; Hildebrand BE; Svensson TH; Nomikos GG Synapse; 2000 Jan; 35(1):15-25. PubMed ID: 10579804 [TBL] [Abstract][Full Text] [Related]
13. Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia. Harris AC; Rothwell PE; Gewirtz JC Psychopharmacology (Berl); 2008 Mar; 196(4):649-60. PubMed ID: 18026718 [TBL] [Abstract][Full Text] [Related]
14. Corticotropin-releasing factor (CRF) and α 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats. Park PE; Vendruscolo LF; Schlosburg JE; Edwards S; Schulteis G; Koob GF Int J Neuropsychopharmacol; 2013 Sep; 16(8):1867-75. PubMed ID: 23590881 [TBL] [Abstract][Full Text] [Related]
15. Nicotine withdrawal disrupts both foreground and background contextual fear conditioning but not pre-pulse inhibition of the acoustic startle response in C57BL/6 mice. André JM; Gulick D; Portugal GS; Gould TJ Behav Brain Res; 2008 Jul; 190(2):174-81. PubMed ID: 18367257 [TBL] [Abstract][Full Text] [Related]
16. Anxiogenic-like effects of opiate withdrawal seen in the fear-potentiated startle test, an interdisciplinary probe for drug-related motivational states. Fendt M; Mucha RF Psychopharmacology (Berl); 2001 May; 155(3):242-50. PubMed ID: 11432686 [TBL] [Abstract][Full Text] [Related]
18. Time-dependent changes in nicotine behavioral responsivity during early withdrawal from chronic cocaine administration and attenuation of cocaine sensitization by mecamylamine. Szabo ST; Fowler JC; Froeliger B; Lee TH Behav Brain Res; 2014 Apr; 262():42-6. PubMed ID: 24412684 [TBL] [Abstract][Full Text] [Related]
19. Interactions between age and the aversive effects of nicotine withdrawal under mecamylamine-precipitated and spontaneous conditions in male Wistar rats. Shram MJ; Siu EC; Li Z; Tyndale RF; Lê AD Psychopharmacology (Berl); 2008 Jun; 198(2):181-90. PubMed ID: 18385986 [TBL] [Abstract][Full Text] [Related]
20. Mecamylamine blocks the development of tolerance to nicotine in rats: implications for the mechanisms of tolerance. McCallum SE; Caggiula AR; Epstein LH; Saylor S; Ploskina T; Sved AF Psychopharmacology (Berl); 1999 Jan; 141(3):332-8. PubMed ID: 10027516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]